awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47203904-42C5601C-AC51-4FA8-8DA3-B7440F921472
Q47203904-42C5601C-AC51-4FA8-8DA3-B7440F921472
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47203904-42C5601C-AC51-4FA8-8DA3-B7440F921472
The therapeutic potential of cell cycle targeting in multiple myeloma.
P2860
Q47203904-42C5601C-AC51-4FA8-8DA3-B7440F921472
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47203904-42C5601C-AC51-4FA8-8DA3-B7440F921472
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
220177329f4be5ce36c1b9c8cb3b55ac4ca825ef
P2860
A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191.